Literature DB >> 9748548

On the origins of tumor mutations in cancer genes: insights from the p53 gene.

M Hollstein1, G Moeckel, M Hergenhahn, B Spiegelhalder, M Keil, G Werle-Schneider, H Bartsch, J Brickmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9748548     DOI： 10.1016/s0027-5107(98)00131-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN： 0027-5107            Impact factor:   2.433


× No keyword cloud information.
  6 in total

1.  Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; A Aboukameel; Zhiwei Wang; Sanjeev Banerjee; Syed F Zafar; Anton-Scott Goustin; K Almhanna; Dajun Yang; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Curr Cancer Drug Targets       Date:  2010-05       Impact factor: 3.428

Review 2.  Towards an understanding of the role of p53 in adrenocortical carcinogenesis.

Authors:  Jonathan D Wasserman; Gerard P Zambetti; David Malkin
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

3.  Regional differences in breast cancer biomarkers in american Indian and Alaska native women.

Authors:  Judith S Kaur; Robert A Vierkant; Timothy Hobday; Daniel Visscher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

Review 4.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

5.  p53 mutations in urinary bladder cancer.

Authors:  P Berggren; G Steineck; J Adolfsson; J Hansson; O Jansson; P Larsson; B Sandstedt; H Wijkström; K Hemminki
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

6.  A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients.

Authors:  Gourab Saha; Richa Singh; Argha Mandal; Subrata Das; Esita Chattopadhyay; Prasun Panja; Paromita Roy; Navonil DeSarkar; Sumit Gulati; Supriyo Ghatak; Shibajyoti Ghosh; Sudeep Banerjee; Bidyut Roy; Saurabh Ghosh; Dipankar Chaudhuri; Neeraj Arora; Nidhan K Biswas; Nilabja Sikdar
Journal:  Mol Med       Date:  2020-06-17       Impact factor: 6.354
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.